title: Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.
abstract: Reduced epithelial cadherin (E-cad) is a hallmark of invasive carcinomas that have acquired epithelial-mesenchymal transition (EMT) phenotypes. Here we show that down-regulated E-cad expression induced by transforming growth factor-β (TGF-β) and EMT preceded breast cancer outgrowth in three-dimensional (3D) organotypic assays and in the lungs of mice. Pharmacological inhibitors against focal adhesion kinase prevented metastatic outgrowth of newly seeded organoids, but not that of their fully established counterparts. Interrogating the D2-HAN (hyperplastic alveolar nodule) model of breast cancer dormancy and metastasis showed that dormant D2.OR cells produced branched organoid morphologies in 3D-cultures, and expressed robust quantities of E-cad that was uncoupled from regulation by TGF-β. In contrast, metastatic D2.A1 organoids were spherical and wholly lacked E-cad expression. Interestingly, D2.A1 cells engineered to re-express E-cad formed branched organoids, down-regulated β1 integrin expression, and failed to undergo metastatic outgrowth. The tumor-suppressing function of E-cad was inactivated by increased microenvironmental rigidity, and was not recapitulated by expression of an E-cad mutant lacking its extracellular domain. Twist expression, but not that of Snail, reinitiated metastatic outgrowth in dormant D2.OR cells. Our findings show that EMT and its down-regulated expression of E-cad circumvent breast cancer dormancy in part by facilitating β1 integrin expression necessary for metastatic outgrowth.
authors: Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.
authors: Michael K
authors: MK
authors: Wendt
authors: Molly A
authors: MA
authors: Taylor
authors: Barbara J
authors: BJ
authors: Schiemann
authors: William P
authors: WP
authors: Schiemann
references: Cancer Res. 2007 Apr 15;67(8):3752-8
references: 17440088
references: J Cell Biol. 1997 Apr 7;137(1):231-45
references: 9105051
references: Breast Cancer Res. 2009;11(5):R68
references: 19740433
references: Cancer Res. 1998 May 15;58(10):2063-6
references: 9605742
references: Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15449-54
references: 20713713
references: Cell Growth Differ. 1999 Sep;10(9):629-38
references: 10511313
references: Cell Signal. 2011 Jun;23(6):951-62
references: 20940046
references: Breast Cancer Res. 2006;8(4):R42
references: 16859511
references: Stem Cells. 2010 Aug;28(8):1435-45
references: 20572012
references: J Cell Sci. 2006 Jan 15;119(Pt 2):283-91
references: 16390868
references: Cancer Res. 2008 Mar 15;68(6):1935-44
references: 18339875
references: J Mammary Gland Biol Neoplasia. 2007 Sep;12(2-3):99-102
references: 18769505
references: Cell. 2008 May 16;133(4):704-15
references: 18485877
references: Cell Cycle. 2008 Aug;7(15):2306-14
references: 18677107
references: Br J Cancer. 1992 May;65(5):641-8
references: 1586590
references: J Biol Chem. 2000 Jan 28;275(4):2727-32
references: 10644736
references: Cancer Res. 2011 Jan 1;71(1):245-54
references: 21199805
references: Future Oncol. 2009 Oct;5(8):1145-68
references: 19852727
references: Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10290-5
references: 19502425
references: Cell. 2009 Aug 21;138(4):645-659
references: 19682730
references: Clin Exp Metastasis. 2008;25(6):685-93
references: 18236164
references: Cancer Res. 2008 May 15;68(10):3645-54
references: 18483246
references: J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90
references: 20467795
references: Clin Exp Metastasis. 2008;25(8):843-54
references: 18696232
references: Br J Cancer. 2006 Mar 13;94(5):661-71
references: 16495925
references: Exp Cell Res. 2008 Jan 1;314(1):143-52
references: 17949712
references: J Natl Cancer Inst. 2002 Oct 2;94(19):1494-503
references: 12359858
references: Clin Exp Metastasis. 1994 Nov;12(6):357-67
references: 7923988
references: Development. 1996 Sep;122(9):2895-902
references: 8787762
references: J Biol Chem. 2009 Dec 4;284(49):34145-56
references: 19822523
references: J Cell Biol. 1994 Dec;127(6 Pt 2):2021-36
references: 7806579
references: Mol Cancer. 2010 Jul 07;9:179
references: 20609236
references: J Cancer Res Clin Oncol. 2006 Dec;132(12):795-803
references: 16821070
references: Cancer Res. 1996 Sep 1;56(17):4063-70
references: 8752180
references: Cancer Res. 2005 Jun 1;65(11):4698-706
references: 15930288
references: J Cell Physiol. 2007 Nov;213(2):374-83
references: 17680632
references: Cancer Res. 2008 Aug 1;68(15):6241-50
references: 18676848
references: Nat Cell Biol. 2000 Feb;2(2):76-83
references: 10655586
references: Oncogene. 2008 Feb 28;27(10):1461-71
references: 17724466
references: Nat Rev Cancer. 2002 Jun;2(6):442-54
references: 12189386
references: J Biol Chem. 2001 Dec 14;276(50):46707-13
references: 11590169
references: Oncogene. 2010 Dec 9;29(49):6485-98
references: 20802523
references: Oncogene. 2008 Feb 21;27(9):1218-30
references: 17724470
references: Carcinogenesis. 2008 Feb;29(2):244-51
references: 18174260
references: Cancer Cell. 2008 Jul 8;14(1):79-89
references: 18598946
references: Nat Rev Cancer. 2009 Feb;9(2):108-22
references: 19165226
references: Cancer Res. 2010 Jul 15;70(14):5706-16
references: 20570886
references: Cell. 2004 Jun 25;117(7):927-39
references: 15210113
references: J Natl Cancer Inst. 2000 Nov 1;92(21):1717-30
references: 11058615
references: Carcinogenesis. 2008 Nov;29(11):2227-35
references: 18725385
references: Mol Biol Cell. 2009 Apr;20(8):2207-17
references: 19225155
references: Cancer Res. 1992 Mar 15;52(6):1399-405
references: 1540948
references: Matrix Biol. 2002 Oct;21(6):525-32
references: 12392763
references: Cancer Res. 2000 Aug 15;60(16):4346-8
references: 10969774